Skip to text Skip to main menu

CELLPURICS

GLOBAL CRO SERVICE

NHP Efficacy Evaluation & GLP Toxicity Testing

Cellpurix’s Overseas GLP Testing Services are provided through China’s top-tier GLP CROs,
which possess extensive experience in drug approvals for major global markets, including the US, Europe, China, and Korea.

As the sole official domestic agent for Biocytogen, Cellpurix provides import agency services for all of Biocytogen’s humanized mouse and cell line models,
along with comprehensive efficacy evaluation services.

23,500m² NHP Breeding Center with a Capacity of Approx. 25,000 Primates

Total GLP Facility Area

20,600㎡

Facility Area
Analytical Center

860㎡

Analysis Center
Animal Housing

12,000㎡

Animal Rooms
Laboratory Area

9,460㎡

Labs
Dedicated GLP Zone

11,365㎡

GLP Zone
Securing a stable animal supply chain through an in-house primate breeding center,
enabling rapid study initiation without delay and cost-effective solutions.
NHP Efficacy Evaluation Platform

Oncology and Immunology Diseases

Receptor Occupancy (RO) Studies

Vaccine Evaluation

Stroke and Parkinson’s Disease

Metabolic Diseases

Inflammatory and Cardiovascular Diseases

Behavioral Pharmacology

mRNA Vaccine Immunogenicity

CDX Animal Models

Diabetes and Obesity

GLP-based Toxicity Testing Platform

Single and Repeated Dose Toxicity (Rodent & Non-rodent)

Local Tolerance Testing

Reproductive Toxicity (Stages I, II, III)

Immunogenicity Testing

Genotoxicity (Ames, Micronucleus, Chromosomal Aberration, Mouse Lymphoma)

Safety Pharmacology

Toxicokinetics (TK)

Carcinogenicity Studies

PET-CT Pre-dose
Pre-dose PET-CT (¹⁸F-FPCIT)
PET-CT Post-dose
Post-dose (33W) PET-CT (¹⁸F-FPCIT) of iPS Cells

Proven Track Record in GLP Studies, Passing Inspections by FDA, OECD, and PMDA

Extensive experience in IND approvals across various platforms including Small Molecules, Proteins/Antibodies, ADC, Peptides, CGT, and Nucleic Acids.

50%
Reduction in Project Lead Time
Time Reduction
80%
Reduction in R&D Errors
Error Reduction